- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UP-50-0070009

Zipka Pharmaceuticals Private Limited
About Zipka Pharmaceuticals Private Limited
Data last updated:
Zipka Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 12 August 2022.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24290UP2022PTC168976.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ram Dheeraj Singh and Antima Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Deepak Dubey E – 166 Transport Nagar, Lucknow, Uttar Pradesh, India – 226012.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.24 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹14,538 (net margin 0.8%) and EBITDA of ₹34,537 (EBITDA margin 2%).
As per MCA filings, the company has open charges of ₹8.5 Lakh on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Zipka Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0070009).
Company details
Recognitions & Rankings of Zipka Pharmaceuticals
Contact details
Zipka Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh.
- Registered AddressC/O Deepak Dubey E – 166 Transport Nagar, Lucknow, Uttar Pradesh, India – 226012
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zipka Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Zipka Pharmaceuticals Private Limited, buy the company report.
Financials of Zipka Pharmaceuticals Private Limited
FY 2025 filings availableZipka Pharmaceuticals Private Limited reported revenue of ₹17.24 Lakh (up 429% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 429% in the latest year. EBITDA rose 592% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹34,537 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹14,538 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2% | |
| Net Profit Margin | 0.8% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Zipka Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zipka Pharmaceuticals Private Limited
Zipka Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ram Dheeraj Singh | Director | 12 Aug 2022 | 4 Years 2 Months | Current |
| Antima Singh | Director | 04 Jan 2024 | 2 Years 9 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Oct 2024 | 101039277 | Idbi Bank Limited | ₹8.5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Zipka Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by Alencure Biotech Private Limited | Pending |
To see the full case history of Zipka Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zipka Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Zipka Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Zipka Pharmaceuticals Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Shashi Prkash Pandey ceased to be Director on 10 Jan 2024.
Frequently asked questions
Zipka Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 12 August 2022 (4+ years old) and is registered under CIN U24290UP2022PTC168976.
Zipka Pharmaceuticals has 2 current directors:
- Ram Dheeraj Singh - Director
- Antima Singh - Director
The latest financial statements of Zipka Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Zipka Pharmaceuticals is U24290UP2022PTC168976. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zipka Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Zipka Pharmaceuticals was incorporated on 12 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Shashi Prkash Pandey ceased to be Director on 10 Jan 2024. Antima Singh was appointed as Director on 04 Jan 2024. Ram Dheeraj Singh was appointed as Director on 12 Aug 2022.
Yes, Zipka Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0070009).
The registered office of Zipka Pharmaceuticals is at CO Deepak Dubey E – 166 Transport Nagar, Lucknow, Uttar Pradesh, India – 226012.
Zipka Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.